peutic gene; the gene remains episomal and does not intein renal disease. The past decade has been marked by significant grate into the host cell genome. Repeated applications advances in the application of gene transfer into living cells of could overcome this problem but are limited by the imanimals and humans. These approaches have been tested in a mune and inflammatory responses that the virus induces. few animal models of inherited and acquired renal diseases, Adeno-associated virus (AAV), a parvovirus, offers sevincluding carbonic anhydrase II deficiency [1] and experimental glomerulonephritis [2, 3]. Gene transfer into proximal tubular eral advantages in that it lacks immunogenic viral procells has been successfully accomplished by intrarenal arterial teins, can efficiently transduce nondividing cells, and ininfusion of a liposomal complex [4] or an adenoviral vector tegrates into the host genome at a specific site within [5]. Tubular cells from the papilla and medulla have been human chromosome 19q [6]. The major disadvantages of selectively transduced by retrograde infusion into the pelvithis system are the restricted insert size the vector can calyceal system of an adenoviral vector containing a reporter for ␤-galactosidase [5]. Although the results of these initial accommodate (approximately 4.4 kB), difficulties in prostudies are promising, further studies to optimize viral vectors, ducing sufficient purified virus for gene therapy, and maximize gene delivery, minimize side-effects, and develop
loss of site-specific integration with recombinant vectors cell-specific and long-term regulated gene expression are critideveloped for gene therapy. Chimeric viral vectors are cal to the success of gene therapy targeted to specific compartnow being developed that incorporate the favorable atments of the kidney. Our recent efforts have focused on defining the cellular pathways responsible for viral entry and tributes of two different viral vectors. infection into renal epithelial cells using herpes simplex virus HSV has received little attention in the arena of gene (HSV) as a model vector. We anticipate that a solid understandtherapy for renal disease. Rather, the focus has been on ing of the basic scientific principles underlying viral entry and the use of HSV in suicide gene therapy of tumors and gene expression into specific populations of renal cells will facilitate the design of successful therapeutic viral-based gene its role as a vector for delivery of genes to the nervous transfer strategies. system. However, distinct advantages of HSV as a vector suggest that further exploration of its potential role in treating renal diseases is warranted. Possibly the greatest CANDIDATE VIRAL VECTORS advantage of HSV as a vector is its large genome size Optimal viral vectors for gene delivery should exhibit (approximately 150,000 bp), which could readily accomcell tropism for target cell type, high transduction effimodate up to 30 to 40 kb of foreign genetic material ciency, and little or no cytotoxicity and should elicit mini- [7, 8] . This would allow simultaneous delivery of multiple mal or no immune response. Retroviruses permit efficient genes or a very large gene, which may be important in and stable transduction. These vectors are advantageous some disease states such as autosomal polycystic kidney because they do not induce an immune response. Howdisease caused by mutations in the very large protein ever, random integration of the delivered gene into dividpolycystin 1 (approximately 460 kD), the product of the ing cells raises concerns about possible insertional muta-PKD1 gene [9, 10] . Moreover, HSV grows easily in cell genesis and a risk of malignant transformation. In organs culture and replicates to high titers (10 8 to 10 9 ), faciliwith a low mitotic index, such as the mature kidney, retrotating production of sufficient stocks for therapeutic viral vectors may also have limited efficiency of transducpurposes. The virus is well characterized with a genome tion. Adenoviral vectors can transduce a variety of cell that is maintained as a concatemerized circular or linear types but are limited by transient expression of the theraepisome in infected cells. HSV readily infects epithelial cells, including renal tubular epithelia, as shown later in Our studies focus on the potential role of HSV as a These vectors are replication defective and can establish viral vector for gene therapy for renal diseases by investia productive infection only on complementing cell lines gating how the virus attaches to and invades target renal that express the corresponding deleted essential viral cells. Using Vero cells, a cell line derived from the kidney gene(s) in trans. The duration of gene expression in renal of a normal adult African green monkey, the pathway cells infected with such vectors and whether repeated of HSV-1 entry has been partially characterized. Briefly, applications of such HSV vectors would be limited by invasion of Vero cells in culture by HSV requires binding the immune response are not known.
of virus to receptors on the cell surface, followed by An alternative strategy is the HSV amplicon system. fusion of the virion envelope with the cell plasma mem-This approach involves introducing the gene(s) of interbrane. This process is complex and involves multiple est into a plasmid containing the HSV origin of replicainteractions between viral envelope glycoproteins and tion and packaging signal. This construct is then transcell surface components. The initial interaction is binding fected into a cell line, which is superinfected with helper of viral envelope glycoproteins gC and/or gB to cell survirus. The helper virus provides replication and packagface HS [16] [17] [18] . The evidence includes the following ing functions in trans, enabling the amplicon to be packkey observations. Cells devoid of HS (but not other glyaged into mature viral particles. Several different helper cosaminoglycans) because of enzymatic treatment or geviruses have been developed, and recent modifications netic mutation have greatly reduced the numbers of rehave resulted in increased yields of packaged vectors ceptors for HSV binding. These cells are poorly infected free of contamination from helper-virus [11] . Because by HSV but are unaltered in their susceptibility to other HSV DNA replication occurs via a rolling circle mechaviruses, such as vesicular stomatitis virus [19, 20] . Soluble nism, amplicon vectors contain multiple copies of the heparin, which is structurally similar to HS, inhibits the plasmid. Since these vectors contain no virus-encoded binding of HSV to cells [20] . In contrast, chondroitin sulgenes, they have the potential to provide long-term gene fate, a different glycosaminoglycan, fails to inhibit viral expression in transduced cells and to induce little or no binding or infection. The viral envelope glycoproteins immune response.
gC and gB bind selectively and independently to heparin-Selection of an optimal viral vector system for a spesepharose columns under physiological conditions [16] . cific gene therapy should take into consideration the Deletion of gC alone, but not gB, reduces, but does not features described previously here (for example, genome abolish, specific viral binding activity, whereas deletion size, ability to infect dividing or nonmitotic cells, whether of both gC and gB abolishes viral binding [16, 17] . To-DNA integrates or remains episomal, and propensity to gether, these results suggest that initial binding of HSV-1 induce a host cell response), as well as the pathway of to Vero cells is mediated principally by interactions of viral entry. The importance of the latter has only recently viral envelope glycoprotein gC with cell surface HS moiebeen recognized and has been underscored by experities. Thus, although gC is nonessential in cell culture, ences with adeno-associated virus (AAV) vectors for viral vectors deleted for this glycoprotein would be precystic fibrosis replacement gene therapy. Recent studies dicted to exhibit reduced binding activity and efficiency have shown that the apical surface of human airway of gene transduction. epithelia is resistant to infection by AAV2, presumably Expression of HS proteoglycans is cell and tissue-type because of a lack of sufficient heparan sulfate (HS) prospecific and is developmentally regulated [21] [22] [23] [24] [25] . The teoglycans on the apical surface, an important receptor HS chain consists of alternating residues of an amino sugar for AAV2 binding and entry [12, 13] . This has led to a and a uronic acid. As the chains polymerize, they unfocus on other serotypes of AAV, such as AAV5, which dergo various sulfation and epimerization reactions that appear to adhere to cells in an HS-independent fashion. result in structurally quite heterogeneous sequences dif-In addition, levels of transduction for recombinant AAV fering in sequence, chain length, and degree, extent, and vectors vary depending on cell type, with poorly differenpattern of sulfations. These structurally diverse sequences tiated cells transducing more efficiently than well-differmay be differentially expressed on various cell types entiated epithelial cell types [13] . The efficiency of AAVand on the apical or basolateral surfaces of polarized mediated ex vivo gene transfer is limited to regions of epithelial cells. Knowledge of the specific HS sequence epithelial injury and preferentially targets basal-like cells that serves as the receptor for initial viral attachment [14, 15] . Together, these studies highlight the importance and its relative expression on target cells is critical to of defining, at a molecular level, the pathway of entry the success of viral gene therapy. for candidate viral vectors and testing viral vectors in Following the initial HS attachment step, glycoprotein D (gD) binds to cellular coreceptors. Several candidate primary culture systems.
S-5
gD coreceptors have been identified, including a member of the tumor necrosis factor (TNF) receptor family called herpes virus entry mediator A (HveA), and two members of the immunoglobulin superfamily, termed HveB (nectin2␣) and HveC (nectin-1) [26] [27] [28] [29] . Most recently, a unique HS sequence has been shown to serve as a HSV-1-specific gD coreceptor [30] . These different gD coreceptors may be differentially expressed on various cell types, and the redundancy of the coreceptors may explain, in part, the diverse tropism of HSV. The specific gD coreceptor expression on human renal epithelial cells has not yet been characterized.
How the interactions of gC and gB with HS sequences and gD with its coreceptors trigger penetration is not known. Penetration is mediated by a pH-independent fusion of the virion envelope with the cell plasma membrane and requires the concerted action of gB, gD, and hetero-oligomers of gH-gL [31] .
We recently explored the possibility that binding of virus to cell surfaces might trigger activation of a signal transduction pathway and facilitate viral entry [32]. This hypothesis emerged from the observations that other mi-
Fig. 1. Stimulation of cellular protein tyrosine phosphorylation after
crobial receptor-ligand interactions trigger signal transexposure to HSV-1. Vero cells were mock infected or exposed to 10 duction pathways, candidate coreceptors for gD are linked PFU/cell of HSV-1(17) for 5, 10, or 30 minutes. Cell lysates were to these pathways, and the common role of HS is as a prepared and analyzed by immunoprecipitation with PY20-agarose (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA). Immunopre-receptor for growth factors (which act via signal trans- serotype of HSV (Fig. 1) [32]. However, no phosphorylation is detected when cells are exposed to a mutant virus deleted in gL (but expressing gC, gB, and gD at the cell surface), which presumably binds to HS and gD corecep-were prepared; this virus is phenotypically wild type but genotypically gL deleted. The stock harvested from com-tors (discussed later here). Phosphorylation is restored when the gL-deletion virus is grown on a complementing plementing gL-expressing 79VB4 cells (gift of P. Spear) had a titer of approximately 10 9 pfu/mL on 79VB4 cells; cell line. These studies suggest that the interactions of gC or gB with HS and gD with its coreceptor are not no plaques were detected on Vero cells. Changes in [Ca 2ϩ ] i were measured in individually identified Vero sufficient to induce activation of this pathway.
One possible mechanism that could explain how acti-cells (5 to 6 cells per experiment) by digital ratiometric imaging (340 nm/380 nm); a calibration was performed vation of signal transduction pathways might facilitate viral entry is through changes in intracellular Ca 2ϩ con-at the conclusion of each experiment with EGTA/AM and ionomycin, according to standard methodology [34]. centration ([Ca 2ϩ ] i ) and alterations in actin microfilaments. To test this hypothesis, Vero cells were loaded with Results from a representative experiment are shown in Figure 2A . Similar results have been obtained in 15 ex-fura-2-AM for 30 minutes, superfused in the loading chamber with phosphate-buffered saline (PBS) for 15 minutes, periments, although there is individual cell variability in the response. Exposure to HSV-1 results in a rapid and then exposed sequentially to PBS buffer or HSV-1 at a multiplicity of infection of 5 pfu/cell. For these stud-increase in [Ca 2ϩ ] i , which peaks within 40 seconds and rapidly returns to baseline. ies, we selected a virus deleted in an essential viral gene, gL, as a prototypic candidate viral vector for gene ther-
To determine whether the physical binding of virus to cells is sufficient to induce the changes in [Ca 2ϩ ] i , Vero apy. The viral strain HSV-1(KOS)gL86 is a generous gift of P. Spear (Northwestern University, Chicago, IL, cells were loaded with the fura-2-AM dye and were exposed to the KOS-gL86 virus that had been grown on USA). The deletion of gL results in mutant virions that can bind to cells but fail to penetrate [33] . For these studies, noncomplementing cells. This virus is both phenotypically and genotypically gL deleted. Virus harvested from stocks of KOS-gL86 harvested from complementing cells
Fig. 2. Effect of viral entry on intracellular Ca 2؉ ([Ca 2؉ ] i ) in Vero cells. Cells were loaded
with the fluorescent Ca 2ϩ indicator fura-2, and their fluorescence intensity ratios (340 nm/380 nm) were monitored before, during, and after exposure to either PBS or virus. (A) Cells were exposed to HSV(gL86) harvested from complementing cells (phenotypically wild type) and (B) to HSVgL86 harvested from Vero cells, rendering the virus able to bind but unable to penetrate the cells.
noncomplementing Vero cells had a titer of Ͻ10 3 pfu/mL ple, binding of human immunodeficiency virus type 1 to on both Vero and 79VB4 cells, reflecting a low level of the CD4 molecule induces phosphatidylionistol-3-kinase recombinants. The relative concentration of viral parti- [36, 37] . [Ca 2ϩ ] i also appears to play a role in Epsteincles was determined by comparing the optical densitome-Barr virus penetration and human cytomegalovirus cell try of the gD band after sodium dodecyl sulfate-polyfusion [38, 39] . We speculate that changes in [Ca 2ϩ ] i may acrylamide gel electrophoresis and Western blotting, as play an important role in facilitating HSV viral envelopepreviously described [32] . Fura-2-treated cells were excell fusion, perhaps through rearrangements of actin miposed to equivalent particle numbers, and the [Ca 2ϩ ] i crofilaments. Understanding this pathway in human rewas monitored. As shown in Figure 2B, we are studying the pathway of HSV viral entry into spe-proteins and involves a signaling pathway associated with cific populations of human renal tubular epithelial cells.
an increase in [Ca 2ϩ ] i . HSV, a vector in which the large We found that HSV-1 readily infects immortalized genome size would allow delivery of very large genes, normal human renal tubular epithelial cells (Fig. 3) . Consuch as those encoding PKD1, efficiently infects human ditionally immortalized human renal proximal tubule renal epithelial cells. Further exploration of the mecha-(PST), collecting tubule (CT), and thick ascending limb nisms mediating viral entry is critical to the development (TAL) epithelia were plated on collagen-coated Transof optimal vectors to treat diseases unique to specific well (Costar, Cambridge, MA, USA) membrane filters, renal epithelial cell types. grown to 80% confluence in segment-specific media at the permissive temperature 33ЊC and transferred to 37ЊC ACKNOWLEDGMENTS for 10 days to maximize differentiation [40] [41] [42] . Cells 
